Cargando…
Is There an Opportunity for Current Chemotherapeutics to Up-regulate MIC-A/B Ligands?
Natural killer (NK) cells are critical effectors of the immune system. NK cells recognize unhealthy cells by specific ligands [e.g., MHC- class I chain related protein A or B (MIC-A/B)] for further elimination by cytotoxicity. Paradoxically, cancer cells down-regulate MIC-A/B and evade NK cell’s ant...
Autores principales: | Quirk, Kendel, Ganapathy-Kanniappan, Shanmugasundaram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651020/ https://www.ncbi.nlm.nih.gov/pubmed/29089892 http://dx.doi.org/10.3389/fphar.2017.00732 |
Ejemplares similares
-
Editorial: Cancer Metabolism: Molecular Targeting and Implications for Therapy
por: Ganapathy-Kanniappan, Shanmugasundaram
Publicado: (2017) -
Taming Tumor Glycolysis and Potential Implications for Immunotherapy
por: Ganapathy-Kanniappan, Shanmugasundaram
Publicado: (2017) -
Tumor glycolysis as a target for cancer therapy: progress and prospects
por: Ganapathy-Kanniappan, Shanmugasundaram, et al.
Publicado: (2013) -
Augmented Liver Uptake of the Membrane Voltage Sensor Tetraphenylphosphonium Distinguishes Early Fibrosis in a Mouse Model
por: Pandita, Himanshi, et al.
Publicado: (2021) -
Exploring the chemotherapeutic potential of currently used kinase inhibitors: An update
por: Naik, Rajashri R., et al.
Publicado: (2023)